NEW CRYSTALLINE FORM OF 6-HYDROXY-3-{4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY}-2-(4-METHOXYPHENYL)BENZ[B]THIOPHENE HYDROCHLORIDE
OA: closed
Abstract
FIELD: organic chemistry, medicine. ^ SUBSTANCE: invention relates to a new crystalline form of 6-hydroxy-2-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-2-(4-methoxyphenyl)benz[b]thiophene hydrochloride. The compound can be used in inhibition of diseases associated with insufficiency of estrogen including cardiovascular disease, hyperlipidemia and osteoporosis and in inhibition of pathological states, such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, endometrium benign hyperplasia, central nervous system disorders including Alzheimer's disease. The compound is prepared by recrystallization of arzoxyphene from tetrahydrofuran. The prepared product exhibits good capacity for crystallization. ^ EFFECT: valuable medicinal properties of compound. ^ 3 cl, 5 dwg, 1 tbl, 3 ex
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-06T06:10:23.601157+00:00